EUVIMEDEUVIMED entdecken
Crossref

The 340B Drug Pricing Program, Stakeholder Impacts and Changes: An Asymmetric Value Distribution

Rayan K. Salih, Bhumika S. Devnani, Gehna Shah, Harshita Sharma, John M. York

Journal of Management Policy and Practice · 17.06.2026 · 27 (1)

DOI: 10.33423/c2shqr39 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Management Policy and Practice, online erschienen am 17.06.2026. Verfasst von Rayan K. Salih und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 340B Program has expanded substantially, raising concerns about transparency, oversight, and whether savings benefit patients. This review analyzed key policy developments and stakeholder impacts using a PRISMA–guided systematic review of PubMed and Embase studies published between 1992 and 2024. Fifty-two sources met the inclusion criteria, with AI-assisted summarization and human verification used for analysis. Findings show program growth outpaced oversight: about two-thirds of studies reported limited transparency, and nearly half found financial gains concentrated among hospitals and Federally Qualified Health Centers (FQHCs). Fewer than one-third of studies found measurable improvements in patient affordability or equity. An Input–Moderator–Process–Output (IMPO) framework is proposed to explain the asymmetric distribution of value across stakeholders.

Zitieren

APA

Salih, R. K., Devnani, B. S., Shah, G., Sharma, H., & York, J. M. (2026). The 340B Drug Pricing Program, Stakeholder Impacts and Changes: An Asymmetric Value Distribution. Journal of Management Policy and Practice, 27(1). https://doi.org/10.33423/c2shqr39

Vancouver

Salih RK, Devnani BS, Shah G, Sharma H, York JM. The 340B Drug Pricing Program, Stakeholder Impacts and Changes: An Asymmetric Value Distribution. Journal of Management Policy and Practice. 2026;27(1). doi:10.33423/c2shqr39

BibTeX
@article{Salih2026,
  author = {Salih, Rayan K. and Devnani, Bhumika S. and Shah, Gehna and Sharma, Harshita and York, John M.},
  title = {The 340B Drug Pricing Program, Stakeholder Impacts and Changes: An Asymmetric Value Distribution},
  journal = {Journal of Management Policy and Practice},
  year = {2026},
  volume = {27},
  number = {1},
  doi = {10.33423/c2shqr39}
}
Kostenlos starten →